ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors

Neuroendocrinology

Volumn 91, Issue 4, 2010, Pages 333-340

  Kianmanesh, Reza ^a   Ruszniewski, Philippe ^a,b   Rindi, Guido ^c   Kwekkeboom, Dik ^d   Pape, Ulrich Frank ^e   Kulke, Matthew ^f   Sevilla Garcia, Isabel ^g   Scoazec, Jean Yves ^h   Nilsson, Ola ⁱ   Fazio, Nicola ^j   Lesurtel, Mickael ^k   Chen, Yuan Jia ^l   Eriksson, Barbro ^m   Cioppi, Federica ⁿ   O'Toole, Dermot ^o  

^a HÔPITAL LOUIS MOURIER   (France)

^b BEAUJON HOSPITAL   (France)

^c UNIVERSITY OF PARMA   (Italy)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h EDOUARD HERRIOT HOSPITAL   (France)

ⁱ SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^j EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^k UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^l PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^m UPPSALA UNIVERSITY HOSPITAL   (Sweden)

ⁿ UNIVERSITY OF FLORENCE   (Italy)

^o ST JAMES S HOSPITAL   (Ireland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHROMOGRANIN A; CORTICOSTEROID; DOXORUBICIN; FLUOROURACIL; KI 67 ANTIGEN; MITOMYCIN C; PLATINUM DERIVATIVE; SOMATOSTATIN DERIVATIVE; SPASMOLYTIC AGENT; STREPTOZOCIN; SYNAPTOPHYSIN; TEMOZOLOMIDE;

ABDOMINAL PAIN; ASCITES; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CARCINOID SYNDROME; CARCINOMATOUS PERITONITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; CYTOREDUCTIVE SURGERY; DIAGNOSTIC PROCEDURE; GILLY CLASSIFICATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LAPAROSCOPY; LIVER METASTASIS; LYMPH NODE METASTASIS; MORBIDITY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PERITONEAL CARCINOMATOSIS INDEX; PRIORITY JOURNAL; SCINTIGRAPHY; SMALL INTESTINE OBSTRUCTION; WEIGHT GAIN; WEIGHT REDUCTION; CARCINOMA; DIGESTIVE SYSTEM TUMOR; PATHOLOGY; PERITONEAL NEOPLASMS; PRACTICE GUIDELINE; SECONDARY;

CARCINOMA; DIGESTIVE SYSTEM NEOPLASMS; HUMANS; NEUROENDOCRINE TUMORS; PERITONEAL NEOPLASMS;

EID: 77954659384     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000286700     Document Type: Conference Paper

References (44)

1. Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle FG, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A: Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008; 9: 61-72.
2. Elias D, Sideris L, Liberale G, Ducreux M, Malka D, Lasser P, Duvillard P, Baudin E: Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas. Surgery 2005; 137: 411-416. (Pubitemid 40432038)
3. Ruiz-Tovar J, Alonso HN, Morales CV, Lobo ME, Sanjuanbenito DA, Martinez ME: Peritoneal carcinomatosis secondary to carcinoid tumour. Clin Transl Oncol 2007; 9: 804-805.
4. Vasseur B, Cadiot G, Zins M, Flejou JF, Belghiti J, Marmuse JP, Vilgrain V, Bernades P, Mignon M, Ruszniewski P: Peritoneal carcinomatosis in patients with digestive endocrine tumors. Cancer 1996; 78: 1686-1692.
5. Modlin IM, Lye KD, Kidd M: A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934-959.
6. Glockzin G, Schlitt HJ, Piso P: Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 2009; 7: 5.
7. Royal RE, Pingpank JF Jr: Diagnosis and management of peritoneal carcinomatosis arising from adenocarcinoma of the colon and rectum. Semin Oncol 2008; 35: 183-191.
8. Glehen O, Osinsky D, Beaujard AC, Gilly FN: Natural history of peritoneal carcinomatosis from nongynecologic malignancies. Surg Oncol Clin N Am 2003; 12: 729-739, xiii.
9. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP: Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006; 243: 212-222.
10. Lifante JC, Glehen O, Cotte E, Beaujard AC, Gilly FN: Natural history of peritoneal carcinomatosis from digestive origin. Cancer Treat Res 2007; 134: 119-129.
11. Konig HH, Ulshofer A, Gregor M, von Tirpitz C, Reinshagen M, Adler G, Leidl R: Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002; 14: 1205-1215. (Pubitemid 35476879)
12. O'Toole D, Ducreux M, Bommelaer G, Wemeau JL, Bouche O, Catus F, Blumberg J, Ruszniewski P: Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer 2000; 88: 770-776.
13. Steinmuller T, Kianmanesh R, Falconi M, Scarpa A, Taal B, Kwekkeboom DJ, Lopes JM, Perren A, Nikou G, Yao J, le Fave GF, O'Toole D: Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2008; 87: 47-62.
14. Lips CJ, Lentjes EG, Hoppener JW: The spectrum of carcinoid tumours and carcinoid syndromes. Ann Clin Biochem 2003; 40: 612-627.
15. Dromain C, de Baere T, Lumbroso J, Caillet H, Laplanche A, Boige V, Ducreux M, Duvillard P, Elias D, Schlumberger M, Sigal R, Baudin E: Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol 2005; 23: 70-78.
16. D'Angelica M, Fong Y, Weber S, Gonen M, DeMatteo RP, Conlon K, Blumgart LH, Jarnagin WR: The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol 2003; 10: 183-189.
17. Fernandez-Cruz L, Blanco L, Cosa R, Rendon H: Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors? World J Surg 2008; 32: 904-917.
18. Yan TD, Sim J, Morris DL: Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2007; 14: 1807-1817.
19. Mabrut JY, Fernandez-Cruz L, Azagra JS, Bassi C, Delvaux G, Weerts J, Fabre JM, Boulez J, Baulieux J, Peix JL, Gigot JF: Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients. Surgery 2005; 137: 597-605.
20. D'Angelica M, Jarnagin W, DeMatteo R, Conlon K, Blumgart LH, Fong Y: Staging laparoscopy for potentially resectable noncolorectal, nonneuroendocrine liver metastases. Ann Surg Oncol 2002; 9: 204-209.
21. Inadomi JM, Kapur S, Kinkhabwala M, Cello JP: The laparoscopic evaluation of ascites. Gastrointest Endosc Clin N Am 2001; 11: 79-91.
22. Van Nieuwenhove Y, Delvaux G: Laparoscopic management of neuroendocrine tumours of the pancreas. Acta Chir Belg 1999; 99: 249-252.
23. Kim HJ, D'Angelica M, Hiotis SP, Shoup M, Weber SM: Laparoscopic staging for liver, biliary, pancreas, and gastric cancer. Curr Probl Surg 2007; 44: 228-269.
24. Kianmanesh R, Sauvanet A, Hentic O, Couvelard A, Levy P, Vilgrain V, Ruszniewski P, Belghiti J: Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: a safe approach for radical resection. Ann Surg 2008; 247: 659-665.
25. Pereira PL, Wiskirchen J: Morphological and functional investigations of neuroendocrine tumors of the pancreas. Eur Radiol 2003; 13: 2133-2146.
26. Goh BK, Tan YM, Chung YF, Cheow PC, Ong HS, Chan WH, Chow PK, Soo KC, Wong WK, Ooi LL: Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution. Arch Surg 2008; 143: 956-965.
27. Facchiano E, Scaringi S, Kianmanesh R, Sabate JM, Castel B, Flamant Y, Coffin B, Msika S: Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer. Eur J Surg Oncol 2008; 34: 154-158.
28. Gilly FN, Cotte E, Brigand C, Monneuse O, Beaujard AC, Freyer G, Glehen O: Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol 2006; 32: 597-601.
29. Glehen O, Mohamed F, Gilly FN: Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 2004; 5: 219-228. (Pubitemid 38391217)
30. Jacquet P, Sugarbaker PH: Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996; 82: 359-374.
31. Sugarbaker PH: A curative approach to peritoneal carcinomatosis from colorectal cancer. Semin Oncol 2005; 32:S68-S73.
32. Sarmiento JM, Que FG: Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am 2003; 12: 231-242.
33. Kianmanesh R, Scaringi S, Sabate JM, Castel B, Pons-Kerjean N, Coffin B, Hay JM, Flamant Y, Msika S: Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 2007; 245: 597-603.
34. Elias D, Lasser P, Ducreux M, Duvillard P, Ouellet JF, Dromain C, Schlumberger M, Pocard M, Boige V, Miquel C, Baudin E: Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery 2003; 133: 375-382.
35. Connolly HM, Pellikka PA: Carcinoid heart disease. Curr Cardiol Rep 2006; 8: 96-101.
36. Lal A, Chen H: Treatment of advanced carcinoid tumors. Curr Opin Oncol 2006; 18: 9-15.
37. Sugarbaker PH: Managing the peritoneal surface component of gastrointestinal cancer. 2. Perioperative intraperitoneal chemotherapy. Oncology (Williston Park) 2004; 18: 207-219.
38. Sugarbaker PH: Managing the peritoneal surface component of gastrointestinal cancer. 1. Patterns of dissemination and treatment options. Oncology (Williston Park) 2004; 18: 51-59.
39. Verwaal VJ, van Ruth S, de Bree E, van Slooten GW, van Tinteren H, Boot H, Zoetmulder FA: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737-3743.
40. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H: 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008; 15: 2426-2432.
41. Reidy DL, Tang LH, Saltz LB: Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors. Nat Clin Pract Oncol 2009; 6: 143-152.
42. Modlin IM, Kidd M, Drozdov I, Siddique ZL, Gustafsson BI: Pharmacotherapy of neuroendocrine cancers. Expert Opin Pharmacother 2008; 9: 2617-2626.
43. Holen K: Therapeutic and palliative options for diffuse neuroendocrine metastatic disease. J Gastrointest Surg 2006; 10: 337-340.
44. Bessoud B, de Baere T, Denys A, Kuoch V, Ducreux M, Precetti S, Roche A, Menu Y: Malignant gastroduodenal obstruction: palliation with self-expanding metallic stents. J Vasc Interv Radiol 2005; 16: 247-253.